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doi:10.1016/j.ejvs.2008.12.016Abstract Objectives: Abdominal aortic aneurysms (AAAs) are associated with an inflammatory
cell infiltrate and enzymatic degradation of the vessel wall. The aim of this study was to detect
increased metabolic activity in the wall of the AAA with 18F-fluorodeoxyglucose (18F-FDG),
mediated by glucose transporter protein (GLUTs), using a dedicated hybrid PET/64-detector CT.
Design, method and materials: 14 patients (All male, mean age 73.6 years, range 61e82) with
AAA under surveillance underwent PET/CT scanning with 175 MBq of intravenous I8F-FDG. The
maximum aneurysm diameter and calcification score were determined on the attenuation
correction CT. A volume of interest was placed on the aneurysm sac and the maximum Standar-
dised Uptake Value (SUVmax) measured.
Results: The mean aneurysm diameter was 5.4 cm (SD 0.8). Two aneurysms had the CT char-
acteristics of inflammatory aneurysms. Twelve aneurysms showed increased FDG uptake
(SUVmax> 2.5). There was no significant difference in FDG uptake between heavily calcified
aneurysms and non-heavily calcified aneurysms (t-test). There was a significant increase in
the FDG uptake in the two inflammatory aneurysms compared to the other twelve aneurysms
(t-test; PZ 0.04).273 696955x7977; fax: þ44 01273 694886.
com (C.W. Kotze).
ty for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
94 C.W. Kotze et al.Conclusion: The findings in this study offer in vivo evidence that the AAA wall shows increased
glucose metabolism, mediated by the GLUTs: this increased metabolic activity as detected by
PET/CT may be present in most AAAs.
ª 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Abdominal aortic aneurysm (AAA) diameter is an important
predictor of risk of aneurysm rupture.1,2 However, some
aneurysms rupture at a small size,2e4 and many large
aneurysms grow to a considerable size without rupture.
Size therefore is not the only determinant for the risk of
rupture. Investigators have shown that anatomical and
dynamic features such as, aneurysm shape, aneurysm wall
calcification and computed wall stress, are also associated
with the risk of AAA rupture.5,6
AAAs are associated with an inflammatory cell infiltrate
and enzymatic degradation of the vessel wall.7e9 Correla-
tion between risk of rupture and biological markers of
inflammation has been demonstrated.10 Furthermore,
immune-mediated processes play a role in initiation of AAA
disease and rupture.11e13 In their immunohistochemical
study, Mochizuki et al. reported that the expression of
glucose transporter protein (GLUTs) was detected in
inflammatory tissue, which showed [14C]FDG uptake higher
than that of normal control muscle.14 18F-FDG accumulates
in macrophage-rich atherosclerotic plaques and demon-
strates that vascular macrophage activity can be quantified
non-invasively.15 Investigators have shown that 18F-FDG
positron emission tomography (PET) can reliably detect
inflammation in atherosclerosis.16 Recently, Reeps et al.
confirmed accurate detection of vascular inflammation by
PET/CT by demonstrating correlation between histologi-
cally assessed macrophage-dense regions and FDG uptake
(rZ 0.93, P< 0.0001).17
In contrast to studies on plaque, a previous study using
PET has shown an increased FDG uptake in only 39% of
aneurysms.7 However, this study assessed larger-size AAAs
(mean AAA diameter 6.3 0.95 cm) with a PET only
scanner. During hybrid PET/CT, an attenuation correction
CT is performed, immediately followed by an 18F-FDG PET
emission scan, whilst maintaining the same patient posi-
tion. The hybrid PET/64-detector CT scanner allows a more
reliable assessment of increased FDG uptake in areas of
interest on a high resolution CT.
Understanding the degree of inflammation and associa-
tions in small AAAs as assessed by hybrid PET/CT may
become increasingly relevant with the implementation of
aneurysm screening.
Preliminary data shows focal uptake of 18F-FDG within
the aneurysm wall in patients with large, rapidly
expanding or symptomatic aneurysms that are prone to
rupture.18 However, the role of hybrid PET/CT, especially
in quantifying the degree of inflammation in patients
with small AAAs under surveillance, remains to be
defined.
The aim of this preliminary study was to detect
increased metabolic activity in AAAs of patients undergoingsurveillance, with FDG-PET/CT. Furthermore this prospec-
tive study assesses the possible association between
aneurysm wall calcification, expansion rate, and increased
FDG Uptake. Detection of inflammation with hybrid PET/CT
in the aneurysm walls may help predict growth rate and
allow evaluation of pharmacological interventions for
suppression of inflammation in small aneurysms.
Material and Methods
Patients
A total of 14 patients (all men) with a mean age of 73.6
years (range 61e82) were prospectively studied. All
patients had infra-renal AAAs and the study group included
twelve small AAAs (<5.5 cm) and two larger-size AAAs
(as measured by ultrasound scan). One of the fourteen
patients was symptomatic and underwent an EVAR (Endo-
vascular aneurysm repair). This patient had a large (6.7 cm)
juxta-renal inflammatory abdominal aortic aneurysm (IAAA)
and presented with associated back pain. The mean
maximum aneurysm diameter in the population studied was
5.4 cm (SD 0.8 cm). Each patient underwent an ultra-
sound scan followed by PET/CT within two weeks of the
ultrasound scan, between December 2007 and February
2008. Exclusion criteria for the study were the presence of
congestive heart failure and/or impaired renal function
(serum creatinine> 1.8 mg/dL). Ethics approval was
obtained from the University College London Research
Ethics committee and regional site specific approval was
obtained from the Brighton & Mid Sussex Research Ethics
committee. All subjects provided written informed
consent. Patient characteristics for co-morbidities and oral
medications are documented in Table 1. Study population
data for patients with non-specific AAAs, undergoing
surveillance, is summarized in Table 2.
Protocol for ultrasound surveillance
All patients underwent ultrasound scans to measure the
size of the aneurysm at intervals of 3, 6 or 12 months. All
scans were performed in the same unit by experienced
Vascular Scientists using standard protocol and equipment.
Protocol for FDG-PET/CT
Patients were instructed to fast for at least 6 h prior to the
FDG-PET/CT. In keeping with recommendations from other
cardiovascular PET studies19,20 images were acquired from
a single bed position 3 h after injecting 175 MBq of 18F-FDG
using a dedicated combined PET/64-detector CT instru-
ment (GE Healthcare Technology, Waukesha, WI). Firstly,
Table 1 Patient demographic data.
Characteristics Surveillance AAAs
(nZ 14)
Mean age (yrs) 73.6
Male M/F 14/0
Max diameter, mean SD, cm 5.4 (0.8)
Asymptomatic 13
Symptomatic 1
Recent expansion 2
Associated back pain 3
Auto-immune disease 1
Family history of AAA 0
Inflammatory AAA 2
Previous major surgery 3
Risk factors, yes/no
Smoking (previous or current) 6/8
Hypertension 6/8
Hyperlipidemia 5/9
Diabetes Mellitus 1/13
CAD 2/12
PVD 1/13
Prior CVA 0/14
Prior CABG 1/13
Malignancy 1/13
Medications, yes/no
Anti-platelet therapy 6/8
B-Blockers 2/12
ACE-inhibitors 1/13
Statin 6/8
Laboratory data, yes/no
Elevated CRP 1/13
Elevated ESR 0/14
Abbreviations: CAD coronary heart disease; PVD, peripheral
vascular disease; CVA, cerebral vascular accident; CABG,
coronary artery bypass grafting; ACE, angiotensin converting
enzyme; CRP, C-reactive protein; ESR, erythrocyte sedimenta-
tion rate.
Table 2 Patient characteristics with non-specific AAAs undergo
Patients
No.
Sex Age Diameter of
AAA on U/S (cm)
Diameter o
on CT (cm)
1 M 78 5.3 5.6
2 M 77 5.7 5.8
3 M 74 3.9 4.5
4 M 76 5.3 5.7
5 M 78 5.1 5.6
6 M 75 4.5 4.5
7 M 75 4.4 5.3
8 M 80 4.6 5.9
9 M 77 4.7 5.5
10 M 83 5.4 6.0
11 M 77 4.5 4.4
12 M 69 4.3 4.7
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64 3.75-mm detectors, a pitch of 1.5 and a 5-mm colli-
mation (140 kVp and 80 mA in 0.8 s) over the patient’s
abdominal aorta. Maintaining the patient position, an
18F-FDG PET emission scan was performed and covered an
area identical to that covered by CT. All acquisitions were
carried out in 2D mode (8 min/bed position). Trans-axial
emission images of 3.27 mm thickness (pixel size 3.9 mm)
were reconstructed using ordered subsets expectation
maximisation (OSEM) with two iterations and 28 subsets.
The axial field of view was 148.75 mm, resulting in 47 slices
per bed position.
Image analysis
PET/CT images were reviewed by two combined radiolo-
gist/nuclear medicine physicians in consensus. One of these
readers had a specialist interest in cardiothoracic PET/CT
(more than 5 years). PET/CT images were loaded onto
a Xeleris workstation (GE Healthcare Technology, Wauke-
sha, WI). The maximum aneurysm diameter and aneurysmal
calcification score were determined on the attenuation
correction CT.
A volume of interest was placed on the aneurysmal sac
(i.e. an area of most intense aortic wall 18F-FDG uptake)
and the maximum Standardised Uptake Value (SUVmax)
measured (Fig. 1).
Statistical analysis
Data analysis was carried out using the statistical package
SPSS version 15.0 for Windows. Unpaired t-test was used
for comparison of FDG uptake and the following groups:
IAAAs and non-IAAAs; heavily calcified AAAs (calcification
score> 10,000) and non-heavily calcified AAAs. The
relationship between increased FDG uptake and annual
expansion was analyzed with Spearman rank correlation. A P
value of less than 0.05 was considered statistically signifi-
cant and SUV values were calculated as mean standard
deviation.ing surveillance.
f AAA Increased FDG
Uptake (SUVmax> 2.5)
Remarks
YES Recent expansion
YES Recent expansion,
prostate cancer
YES
NO Auto-immune disease,
previous major surgery
YES
YES
NO Previous major surgery
YES
YES
YES Previous major surgery
YES
YES Back pain
Figure 1 Axial PET image of the same abdominal aortic
aneurysm as in Fig. 3 with Regions of Interest (ROI) placed on
the lumen and the wall of the aorta.
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Figure 2 Increased FDG uptake (SUVmax> 2.5) compared in
patients with an inflammatory abdominal aortic aneurysms
(IAAAs) and those with non-specific AAAs. A significant differ-
ence between 18F-FDG uptake in the walls of the inflammatory
AAAs and non-specific AAAs is demonstrated (PZ 0.04).
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Two patients had CT characteristics of inflammatory AAA
(IAAA), defined by peri-aortic fibrosis of well-defined soft
tissue density with involvement of adjacent retroperito-
neal structures.21 These two patients, aged 62 and 66
years, both presented with associated back pain and AAAs
that measured 4.8 cm and 6.7 cm on ultrasound respec-
tively. Recent AAA expansion within the last year as
measured by ultrasound was seen in seven patients.
Recent annual expansion 3 mm were observed in three
patients and three patients had a recent annual growth
rate >3 mm and <6 mm (including one IAAA). Two patients
presented with an expansion >6 mm in the last year. The
mean aneurysm calcification score was 7973 (SD 6980).
Four aneurysms were heavily calcified with scores
>10,000.
Relationship between clinical characteristics
and 18F-FDG uptake
Twelve aneurysms showed an increased FDG uptake
(SUVmax> 2.5). No significant correlation was found
between the degree of FDG uptake and recent AAA growth
rate (Spearman’s correlation coefficient; rZ 0.18;
PZ 0.60). Furthermore no association was observed
between crosssectional infra-renal AAA diameter and
SUVmax. (Spearman’s correlation coefficient; rZ0.006;
PZ 0.96). A more marked FDG uptake was observed in the
two patients with IAAA, diagnosed on CT scan prior to PET/
CT. One of these patients was asymptomatic. There was
a significant difference in the degree of FDG uptake
between CT apparent inflammatory and non-specific
aneurysms (Unpaired t-test, tZ 2.30, dfZ 12, CIZ 0.11e
4.02, PZ 0.04). PET/CT revealed no other clinical findings.
Furthermore, only two patients in our study revealed
a SUVmax< 2.5, of which one patient demonstrated a SUV
value of 2.5.Relationship between anatomical characteristics
and 18F-FDG uptake
There was no significant difference in FDG uptake between
heavily calcified aneurysms and non-heavily calcified
aneurysms (Unpaired t-test; tZ1.48, dfZ 12,
CIZ2.65e0.51, PZ 0.17).
Discussion
The use of FDG-PET/CT in vivo has previously been
described in patients with symptomatic and/or large
AAAs.18 We evaluated the role of hybrid FDG-PET/CT to
detect increased non-homogeneous metabolic activity in
small AAAs, in patients undergoing surveillance.
Current pathological concepts suggest that chronic
inflammation and enzymatic degradation play a role in AAA
formation and rupture.7,12,13 Histological findings suggest
that IAAAs are the extreme end of an inflammatory process
responsible for both the IAAAs and other unspecified AAAs.22
This study shows that the majority (nZ 12) of patients
demonstrated an increased FDG uptake (SUVmax> 2.5) in
the aneurysm wall. Inflammatory processes may, therefore,
be present to some extent in most aneurysms. In contrast,
a PET study by Sakalihasan et al. failed to confirm previous
histological findings by reporting increased FDG in only 39%
of their study population.7 The study did not clearly define
a positive PET finding, and positive PET findings may have
been judged solely on appearance. Also patients with
larger-size aneurysms were studied (mean AAA diameter
6.3 0.95 cm) as compared to our study of smaller aneu-
rysms (mean AAA diameter 5.4 0.8 cm). Furthermore, the
study performed PET independent from CT scan, whereas in
our study hybrid PET/CT was used. The benefit of hybrid
PET/CT over independent imaging modalities is described in
the literature.23 Combined PET/CT used in our study,
eliminates the positional discrepancies and some of the
challenges brought on by different test timings when
interpreting investigation findings. Improved test sensitivity
Figure 3 Axial (a) Unenhanced CT, (b) PET, and (c) PET/CT fusion of an abdominal aortic aneurysm showing uptake in the lumen
and increased uptake in the wall of the aorta, which is thickened, compatible with an inflammatory aneurysm. Two of the 14 cases
were inflammatory AAAs.
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explain the higher global SUVmax in our study.
The presence of increased FDG tracer intensity in IAAAs
has been reported.24
An area of most intense aortic wall 18F-FDG uptake was
determined for all the study patients in order to avoid false
high SUVmax values which could be reflected in IAAA
patients due to peri-aortic metabolic or inflammatory
processes. Our study suggests a significant difference
between 18F-FDG uptake in the walls of the inflammatory
AAAs and non-specific AAAs (PZ 0.04) (Figs. 2e4), but is
based on very small numbers. The present study demon-
strates an inhomogeneous degree of increased metabolic
activity in the wall of most AAAs however we did not
directly correlate this with inflammatory processes. Factors
influencing AAA wall inflammatory processes require
investigation and further prospective studies are necessary
to establish the role of PET/CT in quantitative assessment
of inflammation in AAAs and the clinical significance
thereof.
Rapid expansion in large aneurysms and its association
with increased FDG uptake were reported in a previous
study.17 In comparison, our study did not support this
association. Irregular and unpredictable progression of
small AAAs25 and small patient numbers (nZ 14) couldexplain our results. The relationship between FDG uptake
and AAA growth rate and risk of rupture in AAA under
surveillance remains unanswered, although correlating
focal increase in FDG uptake with histological findings from
the rupture site may prove to be impossible.
Maximal AAA diameter measured with CT is significantly
and consistently larger than maximal AAA diameter
measured with ultrasound.26,27 This explains the discrep-
ancy seen in some of the maximal AAA measurements
between ultrasound and CT displayed in this study. This
study confirmed similar findings by another study in that no
relationship between crosssectional infra-renal AAA diam-
eter and increased aortic wall glucose metabolism was
demonstrated17 (Fig. 2). A recent study suggests aneurysm
wall stress to be more predictive of rupture risk than AAA
diameter.6 Further research is required to assess the rela-
tionship between increased glucose metabolism and
increased AAA wall stress.
It is reported that the presence of calcification
increases AAA peak wall stress, suggesting that calcifica-
tion decreases the biomechanical stability of AAAs.28
Another study showed that the FDG uptake site was mostly
distinct from the calcification site and may possibly be
located in areas of metabolic activity of atherosclerotic
changes.29 There was no correlation detected between
Figure 4 Axial (a) Unenhanced CT, (b) PET, and (c) PET/CT fusion of an abdominal aortic aneurysm demonstrating 18FDG
circulating in the arterial and venous lumens and no uptake in the wall of the aorta.
98 C.W. Kotze et al.increased FDG uptake and degree of calcification found
(PZ 0.17). The authors agree that the clinical significance
of the relationship between vascular-wall 18F-FDG uptake
and CT calcifications needs to be assessed by further
prospective studies with long-term follow up.20
Despite the improved reliability of integrated 64 slice
PET/CT there are some limitations that need to be
addressed. The partial volume effect observed in small thin
targets such as the AAA wall may affect the accuracy of
FDG-PET/CT. Results could be more accurate with the
implementation of volume effect correction. Furthermore,
differences in activity or volume could influence the
accuracy of signal interpretation.
It is documented that various malignant tumors express
increased GLUTs and it is suggested that increased GLUT
expression contributes to increased FDG uptake in PET
imaging.24
The findings in this study offer in vivo evidence that AAA
show increased glucose metabolism. Hybrid PET/CT may be
a valuable assessment technique in identifying the role that
increased metabolic activity and inflammation play in AAA
disease.Conflict of Interest Statement
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